MONTREAL, Feb. 25, 2025 /CNW/ - bioM rieux, a world leader in the field of in vitro diagnostics, has achieved a significant milestone with the Health Canada approval of the BIOFIRE SPOTFIRE ...
ATLANTA and SALT LAKE CITY, Dec. 18, 2025 /PRNewswire/ -- WellStreet Urgent Care, an expert in developing and scaling urgent care networks with health system partners, and bioMérieux, a world leader ...
MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary ...
The FDA cleared for commercial distribution a diagnostic panel that tests for multiple respiratory viral and bacterial infections on Feb. 3. The BioFire Spotfire Respiratory Panel is the first ...
Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care diagnostics platform at U.S. sites ATLANTA and SALT LAKE CITY, Sept. 9, 2025 /PRNewswire/ -- ...
On September 9, 2025, Altesa BioSciences announced a partnership with bioMérieux to use the BIOFIRE SPOTFIRE respiratory diagnostic platform as the primary point-of-care tool in its upcoming Phase 2B ...
Influenza A subtype H3, Influenza A subtype H1-2009, Influenza B virus, Parainfluenza virus, Respiratory syncytial virus and Coronavirus SARS-CoV-2. A world leader in the field of in vitro diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback